The European Medicines Agency (EMA) and the European network for Health Technology Assessment (EUnetHTA) published today a report on their implementation of the joint work plan covering the period between November 2012 and December 2015.

The EMA-EUnetHTA collaboration aims to create synergies between regulatory evaluation and health technology assessment (HTA) along the life-cycle of a medicine. The overall goal is to improve efficiency and quality of processes for the benefit of public health in the European Union (EU). Please see the joint press release and the Implementation Report